Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Clopidogrel in Preventing Exacerbations in Patients With Severe COPD: An Open-label Randomized Controlled Trial.

NCT06021990 is registered in ClinicalTrials.gov with Lady Reading Hospital, Pakistan as lead sponsor.

NCT NCT06021990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06021990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Clopidogrel in Preventing Exacerbations in Patients With Severe COPD: An Open-label Randomized Controlled Trial.
Lead sponsor
Lady Reading Hospital, Pakistan
Phase
Phase 3
Overall status
Unknown status
Start date
October 1, 2023
Completion date
December 31, 2024
Enrollment
162 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

copd, copd exacerbation acute